![Tod M. Woolf](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tod M. Woolf
President bij
IPIFINI, Inc.
Profiel
Tod M.
Woolf was the founder of Galena Biopharma, Inc. (founded in 2005) and Sequitur, Inc. (founded in 1996) where he held the title of President & Chief Executive Officer and Chief Executive Officer respectively.
Currently, he is the President at IPIFINI, Inc. (since 2004).
Dr. Woolf received a doctorate degree from Harvard University in 1991 and a graduate degree from Harvard University in 1988.
Actieve functies van Tod M. Woolf
| Bedrijven | Functie | Begin |
|---|---|---|
IPIFINI, Inc. | President | 01-01-2004 |
Eerdere bekende functies van Tod M. Woolf
| Bedrijven | Functie | Einde |
|---|---|---|
Galena Biopharma, Inc.
 Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical products through biopharmaceutical research and development | Oprichter | 05-11-2009 |
Sequitur, Inc.
 Sequitur, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and disease research services | Oprichter | - |
Opleiding van Tod M. Woolf
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
99
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical products through biopharmaceutical research and development | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sequitur, Inc.
Sequitur, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and disease research services | Commercial Services |
IPIFINI, Inc. |
